Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

124.00 

1.30 1.1%

as of Dec 05 '19

52 Week Range:

68.60 124.20


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

DiaSorin S.p.A. develops, manufactures, and distributes immunodiagnostics and molecular diagnostics tests for private and hospital analysis laboratories worldwide. The company offers tests for diagnosis in a range of clinical areas, such as infectious diseases, gastrointestinal infections, bone and mineral metabolism, endocrinology, hypertension, oncology, onco-hematology, and autoimmunity. It also provides various technological platforms, including LIAISON XL and LIAISON XS analyzer systems; and LIAISON MDX instrument, a thermocycler. The company sells its products directly, as well as through an international network of independent distributors. DiaSorin S.p.A. has collaboration with QIAGEN to develop an ultra-sensitive diagnostic test for Lyme disease. DiaSorin S.p.A. was founded in 1968 and is headquartered in Saluggia, Italy.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Equity (BVPS) 2.80
3.96
5.75
6.30
6.53
7.61
8.88
growth rate 41.4% 45.2% 9.6% 3.7% 16.5% 16.7%
Earnings BIT 59.89
102.74
144.93
158.26
137.41
136.58
129.99
155.68
177.53
196.84
207.20
growth rate 71.6% 41.1% 9.2% -13.2% -0.6% -4.8% 19.8% 14.0% 10.9% 5.3%
Avg.PE 20.92
19.53
19.69
10.75
18.80
22.32
24.79
26.37
30.07
32.64
30.84
growth rate -6.6% 0.8% -45.4% 74.9% 18.7% 11.1% 6.4% 14.0% 8.6% -5.5%
ROA 15.84
23.29
23.05
21.61
17.49
15.79
14.85
growth rate 47.0% -1.0% -6.3% -19.1% -9.7% -6.0%
ROE 27.30
37.66
33.88
29.86
24.32
21.25
18.74
growth rate 38.0% -10.0% -11.9% -18.6% -12.6% -11.8%
ROIC 22.60
31.47
30.14
27.74
23.22
20.72
18.52
growth rate 39.3% -4.2% -8.0% -16.3% -10.8% -10.6%
Cur. Ratio 2.23
2.73
2.94
3.34
2.53
4.09
4.76
growth rate 22.4% 7.7% 13.6% -24.3% 61.7% 16.4%
Quick Ratio 1.41
1.88
2.04
2.25
1.77
2.87
3.40
growth rate 33.3% 8.5% 10.3% -21.3% 62.2% 18.5%
Leverage 1.72
1.55
1.42
1.35
1.43
1.27
1.25
growth rate -9.9% -8.4% -4.9% 5.9% -11.2% -1.6%
Balance Sheet Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Acct.Receivable 62.70
75.90
106.00
117.00
114.00
117.44
109.52
105.61
120.26
137.20
145.83
growth rate 21.1% 39.7% 10.4% -2.6% 3.0% -6.7% -3.6% 13.9% 14.1% 6.3%
Acct.Payable 41.00
38.00
37.00
36.60
39.31
40.78
47.67
62.33
57.29
growth rate -7.3% -2.6% -1.1% 7.4% 3.7% 16.9% 30.7% -8.1%
Cur.Assets 125.60
179.40
243.00
269.00
313.00
317.71
390.95
494.33
395.38
485.24
414.86
growth rate 42.8% 35.5% 10.7% 16.4% 1.5% 23.1% 26.4% -20.0% 22.7% -14.5%
Total Assets 264.70
336.90
448.00
474.00
526.00
526.62
605.69
707.91
868.62
945.72
905.94
growth rate 27.3% 33.0% 5.8% 11.0% 0.1% 15.0% 16.9% 22.7% 8.9% -4.2%
Cash 16.80
47.90
62.00
64.00
105.00
105.11
144.86
212.18
130.47
159.34
73.10
growth rate 185.1% 29.4% 3.2% 64.1% 0.1% 37.8% 46.5% -38.5% 22.1% -54.1%
Inventory 41.40
50.30
68.00
81.00
84.00
86.44
101.32
106.19
128.87
142.80
160.40
growth rate 21.5% 35.2% 19.1% 3.7% 2.9% 17.2% 4.8% 21.4% 10.8% 12.3%
Cur.Liabilities 56.40
65.80
83.00
81.00
124.00
77.63
82.12
82.44
131.88
141.12
138.45
growth rate 16.7% 26.1% -2.4% 53.1% -37.4% 5.8% 0.4% 60.0% 7.0% -1.9%
Liabilities 110.60
119.10
132.00
123.00
161.00
112.48
122.12
120.75
205.23
203.77
201.21
growth rate 7.7% 10.8% -6.8% 30.9% -30.1% 8.6% -1.1% 70.0% -0.7% -1.3%
LT Debt 31.20
27.90
23.00
13.00
5.00
0.42
0.21
27.00
27.29
0.10
0.08
growth rate -10.6% -17.6% -43.5% -61.5% -91.5% -50.4% 12,757.1% 1.1% -99.6% -20.6%
Equity 154.10
217.90
315.90
351.20
365.10
413.95
483.37
586.81
662.82
741.42
704.73
growth rate 41.4% 45.0% 11.2% 4.0% 13.4% 16.8% 21.4% 13.0% 11.9% -5.0%
Common Shares 55.00
55.00
55.00
55.00
54.00
55.95
55.95
55.95
55.95
55.95
55.95
growth rate 0.0% 0.0% 0.0% -1.8% 3.6% 0.0% 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Capital Expenditures 13.70
19.40
23.00
27.00
28.00
28.08
28.10
27.17
30.03
33.27
33.25
growth rate 41.6% 18.6% 17.4% 3.7% 0.3% 0.1% -3.3% 10.5% 10.8% -0.1%
Cash Dividends 5.50
0.00
0.00
21.90
25.00
27.18
29.92
32.94
35.72
43.81
46.89
growth rate -100.0% 14.2% 8.7% 10.1% 10.1% 8.5% 22.6% 7.0%
Cash From OA 47.80
64.20
96.00
109.00
111.00
107.72
119.85
138.45
165.60
167.44
209.88
growth rate 34.3% 49.5% 13.5% 1.8% -3.0% 11.3% 15.5% 19.6% 1.1% 25.4%
FCF per Share 0.52
0.67
1.22
1.45
1.43
1.39
1.64
growth rate 28.9% 82.1% 18.9% -1.4% -2.8% 18.0%
Sale Purchase of Stock 2.27
0.63
17.95
19.70
19.70
growth rate -72.5% 2,767.3% 9.8% 0.0%
FCF 29.00
37.00
67.00
80.00
78.00
76.00
89.00
111.28
135.57
134.17
176.63
growth rate 27.6% 81.1% 19.4% -2.5% -2.6% 17.1% 25.0% 21.8% -1.0% 31.7%
Income Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Sales 244.60
304.10
405.00
440.00
434.00
434.85
443.77
499.18
569.31
637.49
669.20
growth rate 24.3% 33.2% 8.6% -1.4% 0.2% 2.1% 12.5% 14.1% 12.0% 5.0%
Op.Income 70.80
106.40
90.00
100.00
88.00
136.58
129.99
155.68
177.53
196.84
207.20
growth rate 50.3% -15.4% 11.1% -12.0% 55.2% -4.8% 19.8% 14.0% 10.9% 5.3%
IBT 59.90
103.70
144.90
158.30
137.40
129.34
128.12
150.10
168.20
178.71
204.37
growth rate 73.1% 39.7% 9.3% -13.2% -5.9% -0.9% 17.2% 12.1% 6.3% 14.4%
Net Income 37.50
70.00
90.00
100.00
88.00
83.03
84.07
100.42
112.38
139.88
158.13
growth rate 86.7% 28.6% 11.1% -12.0% -5.7% 1.3% 19.4% 11.9% 24.5% 13.1%
EPS 0.68
1.27
1.64
1.81
1.61
1.53
1.55
growth rate 86.8% 29.1% 10.4% -11.1% -5.0% 1.3%
Gross Profit 160.60
213.60
285.00
314.00
297.00
299.66
298.74
341.90
389.15
431.90
455.77
growth rate 33.0% 33.4% 10.2% -5.4% 0.9% -0.3% 14.5% 13.8% 11.0% 5.5%
R&D 13.80
16.10
19.30
21.50
23.40
23.95
24.99
26.16
37.72
43.63
45.08
growth rate 16.7% 19.9% 11.4% 8.8% 2.3% 4.4% 4.7% 44.2% 15.7% 3.3%

Quarterly Statements

Item Name Sep '18 Dec '18 Mar '19 Jun '19 Sep '19
Earnings BIT 46.70
56.60
53.60
57.22
55.60
growth rate 21.2% -5.3% 6.8% -2.8%
Balance Sheet Sep '18 Dec '18 Mar '19 Jun '19 Sep '19
Acct.Receivable 145.83
136.26
growth rate -3.3%
Acct.Payable 57.29
52.10
growth rate -4.6%
Cur.Assets 344.00
414.86
286.40
461.37
338.60
growth rate 20.6% -31.0% 61.1% -26.6%
Total Assets 817.50
905.94
815.50
987.65
872.10
growth rate 10.8% -10.0% 21.1% -11.7%
Cash 128.80
73.10
78.30
90.07
132.80
growth rate -43.2% 7.1% 15.0% 47.4%
Inventory 160.40
167.48
growth rate 2.2%
Cur.Liabilities 138.45
154.93
growth rate 5.8%
Liabilities 60.70
201.21
60.80
240.49
61.30
growth rate 231.5% -69.8% 295.5% -74.5%
LT Debt 0.08
growth rate
Equity 756.80
704.73
754.70
747.16
810.80
growth rate -6.9% 7.1% -1.0% 8.5%
Common Shares 658.40
55.95
754.70
55.95
810.80
growth rate -91.5% 1,248.9% -92.6% 1,349.2%
Cash Flow Statement Sep '18 Dec '18 Mar '19 Jun '19 Sep '19
Capital Expenditures 33.25
33.25
16.63
16.63
-16.63
growth rate 0.0% -50.0% 0.0% -100.0%
Cash Dividends 46.89
46.89
49.17
49.17
growth rate 0.0% 4.9% 0.0%
Cash From OA 45.00
76.48
48.00
44.72
81.80
growth rate 70.0% -37.2% -6.8% 82.9%
FCF 11.76
43.23
31.37
28.10
65.17
growth rate 267.8% -27.4% -10.5% 132.0%
Income Statement Sep '18 Dec '18 Mar '19 Jun '19 Sep '19
Sales 162.80
175.20
170.80
179.46
174.80
growth rate 7.6% -2.5% 5.1% -2.6%
Op.Income 46.70
56.60
53.60
57.22
55.60
growth rate 21.2% -5.3% 6.8% -2.8%
IBT 45.80
54.17
52.60
56.48
55.40
growth rate 18.3% -2.9% 7.4% -1.9%
Net Income 35.90
41.33
40.40
43.59
42.70
growth rate 15.1% -2.3% 7.9% -2.0%
EPS
growth rate
Gross Profit 109.20
119.77
118.70
124.58
119.80
growth rate 9.7% -0.9% 5.0% -3.8%
R&D 11.20
11.68
11.70
11.60
11.10
growth rate 4.3% 0.2% -0.8% -4.3%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

B (69.44)

YOY Growth Grade:

C (64.52)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 42.58 43.52 39.77
EPS / Growth 9.9% 2.85 11.5%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 8.9%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 8.9% 10.1% 10.1%
Future PE 17.70 34.18 34.18
Future EPS 6.65 7.45 7.45
Value Price
MOS %
29.11
-76.5%
62.94
-49.2%
62.94
-49.2%
MOS Price 14.55 31.47 31.47
IRT 17.83 16.71 16.71

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.